Results of BCG adjuvant immunotherapy in 100 patients with epidermoid carcinoma of the head and neck

James Y. Suen; Stephen P. Richman; Robert B. Livingston; Evan M. Hersh; Robert Craig; Kenneth Tonymon

doi:10.1016/0002-9610(77)90381-6

Results of BCG adjuvant immunotherapy in 100 patients with epidermoid carcinoma of the head and neck

James Y. Suen, Stephen P. Richman, Robert B. Livingston, Evan M. Hersh, Robert Craig, Kenneth Tonymon

Research output: Contribution to journal › Article › peer-review

12 Scopus citations

Abstract

One hundred patients with advanced, recurrent, or metastatic squamous cell carcinoma of the head and neck were treated with chemotherapy and BCG as adjuvant immunotherapy. The overall response rate was 35 per cent, and the median duration of response was seventeen weeks. BCG does not prolong duration of remission or survival time.

Original language	English (US)
Pages (from-to)	474-478
Number of pages	5
Journal	The American Journal of Surgery
Volume	134
Issue number	4
DOIs	https://doi.org/10.1016/0002-9610(77)90381-6
State	Published - Oct 1977
Externally published	Yes

ASJC Scopus subject areas

Surgery

Access to Document

10.1016/0002-9610(77)90381-6

Cite this

@article{c1c2b511a92047cc8c2e76ee3284f6ce,

title = "Results of BCG adjuvant immunotherapy in 100 patients with epidermoid carcinoma of the head and neck",

abstract = "One hundred patients with advanced, recurrent, or metastatic squamous cell carcinoma of the head and neck were treated with chemotherapy and BCG as adjuvant immunotherapy. The overall response rate was 35 per cent, and the median duration of response was seventeen weeks. BCG does not prolong duration of remission or survival time.",

author = "Suen, {James Y.} and Richman, {Stephen P.} and Livingston, {Robert B.} and Hersh, {Evan M.} and Robert Craig and Kenneth Tonymon",

year = "1977",

month = oct,

doi = "10.1016/0002-9610(77)90381-6",

language = "English (US)",

volume = "134",

pages = "474--478",

journal = "The American Journal of Surgery",

issn = "0002-9610",

publisher = "Elsevier Inc.",

number = "4",

}

TY - JOUR

T1 - Results of BCG adjuvant immunotherapy in 100 patients with epidermoid carcinoma of the head and neck

AU - Suen, James Y.

AU - Richman, Stephen P.

AU - Livingston, Robert B.

AU - Hersh, Evan M.

AU - Craig, Robert

AU - Tonymon, Kenneth

PY - 1977/10

Y1 - 1977/10

N2 - One hundred patients with advanced, recurrent, or metastatic squamous cell carcinoma of the head and neck were treated with chemotherapy and BCG as adjuvant immunotherapy. The overall response rate was 35 per cent, and the median duration of response was seventeen weeks. BCG does not prolong duration of remission or survival time.

AB - One hundred patients with advanced, recurrent, or metastatic squamous cell carcinoma of the head and neck were treated with chemotherapy and BCG as adjuvant immunotherapy. The overall response rate was 35 per cent, and the median duration of response was seventeen weeks. BCG does not prolong duration of remission or survival time.

UR - http://www.scopus.com/inward/record.url?scp=0017762212&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017762212&partnerID=8YFLogxK

U2 - 10.1016/0002-9610(77)90381-6

DO - 10.1016/0002-9610(77)90381-6

M3 - Article

C2 - 911030

AN - SCOPUS:0017762212

SN - 0002-9610

VL - 134

SP - 474

EP - 478

JO - The American Journal of Surgery

JF - The American Journal of Surgery

IS - 4

ER -

Results of BCG adjuvant immunotherapy in 100 patients with epidermoid carcinoma of the head and neck

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this